Lipson, Evan J <br/><br/>
Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade.  [electronic resource] 

 -  Journal for immunotherapy of cancer  2017 
 - 23 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2051-1426 
<br/><br/><label>Standard No.: </label>10.1186/s40425-017-0228-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>B7-H1 Antigen--antagonists & inhibitors<br/>Carcinoma, Basal Cell--drug therapy<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Hedgehog Proteins--antagonists & inhibitors<br/>Humans<br/>Lymphocytes, Tumor-Infiltrating--drug effects<br/>Male<br/>Middle Aged<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Tumor Microenvironment--drug effects